1. Guangdong Provincial Key Laboratory of Bioengineering Medicine, National Engineering Research Center of Genetic Medicine, Institute of Biomedicine, College of Life Science and Technology, Jinan University,Guangdong,Guangzhou,China,510632
2. Department of Gynecology and Obstetrics, The First Affiliated Hospital of Jinan University,Guangdong,Guangzhou,China,510630
3. International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), School of Pharmacy, Jinan University,Guangdong,Guangzhou,China,510632
Kexin Li, Shanrong Shu, Jiahua Zou, et al. m6A regulator-mediated methylation modification patterns and tumor immune microenvironment characterization in endometrial cancer. [J]. Genes & Diseases 1(6):2278-2281(2023)
DOI:
Kexin Li, Shanrong Shu, Jiahua Zou, et al. m6A regulator-mediated methylation modification patterns and tumor immune microenvironment characterization in endometrial cancer. [J]. Genes & Diseases 1(6):2278-2281(2023) DOI: 10.1016/j.gendis.2023.01.021.
m6A regulator-mediated methylation modification patterns and tumor immune microenvironment characterization in endometrial cancer
摘要
Abstract
关键词
Keywords
references
1 M.A. Clarke, B.J. Long, A. Del Mar Morillo, et al.Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis JAMA Intern Med, 178 (9) (2018), pp. 1210-1222
2 L. Zhang, Y. Wan, Z. Zhang, et al.IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression Theranostics, 11 (3) (2021), pp. 1100-1114
3 J. Liu, M.A. Eckert, B.T. Harada, et al.m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer Nat Cell Biol, 20 (9) (2018), pp. 1074-1083